These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 17493801
1. Inhibition of human and rat 11beta-hydroxysteroid dehydrogenase type 1 by 18beta-glycyrrhetinic acid derivatives. Su X, Vicker N, Lawrence H, Smith A, Purohit A, Reed MJ, Potter BV. J Steroid Biochem Mol Biol; 2007 May; 104(3-5):312-20. PubMed ID: 17493801 [Abstract] [Full Text] [Related]
2. Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid. Classen-Houben D, Schuster D, Da Cunha T, Odermatt A, Wolber G, Jordis U, Kueenburg B. J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):248-52. PubMed ID: 19429429 [Abstract] [Full Text] [Related]
3. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2. Kratschmar DV, Vuorinen A, Da Cunha T, Wolber G, Classen-Houben D, Doblhoff O, Schuster D, Odermatt A. J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343 [Abstract] [Full Text] [Related]
4. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Gaware R, Khunt R, Czollner L, Stanetty C, Da Cunha T, Kratschmar DV, Odermatt A, Kosma P, Jordis U, Classen-Houben D. Bioorg Med Chem; 2011 Mar 15; 19(6):1866-80. PubMed ID: 21376605 [Abstract] [Full Text] [Related]
5. Synthesis of novel 3-amino and 29-hydroxamic acid derivatives of glycyrrhetinic acid as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors. Stanetty C, Czollner L, Koller I, Shah P, Gaware R, Cunha TD, Odermatt A, Jordis U, Kosma P, Classen-Houben D. Bioorg Med Chem; 2010 Nov 01; 18(21):7522-41. PubMed ID: 20851614 [Abstract] [Full Text] [Related]
6. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Su X, Vicker N, Ganeshapillai D, Smith A, Purohit A, Reed MJ, Potter BV. Mol Cell Endocrinol; 2006 Mar 27; 248(1-2):214-7. PubMed ID: 16325333 [Abstract] [Full Text] [Related]
7. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol. Morris DJ, Latif SA, Hardy MP, Brem AS. J Steroid Biochem Mol Biol; 2007 May 27; 104(3-5):161-8. PubMed ID: 17459698 [Abstract] [Full Text] [Related]
8. Effects of glycyrrhetinic acid derivatives on hepatic and renal 11beta-hydroxysteroid dehydrogenase activities in rats. Shimoyama Y, Hirabayashi K, Matsumoto H, Sato T, Shibata S, Inoue H. J Pharm Pharmacol; 2003 Jun 27; 55(6):811-7. PubMed ID: 12841942 [Abstract] [Full Text] [Related]
9. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, UI-1499. Byun SY, Shin YJ, Nam KY, Hong SP, Ahn SK. Life Sci; 2015 Jan 01; 120():1-7. PubMed ID: 25447448 [Abstract] [Full Text] [Related]
10. Identification of novel 11β-HSD1 inhibitors by combined ligand- and structure-based virtual screening. Lagos CF, Vecchiola A, Allende F, Fuentes CA, Tichauer JE, Valdivia C, Solari S, Campino C, Tapia-Castillo A, Baudrand R, Villarroel P, Cifuentes M, Owen GI, Carvajal CA, Fardella CE. Mol Cell Endocrinol; 2014 Mar 25; 384(1-2):71-82. PubMed ID: 24447464 [Abstract] [Full Text] [Related]
11. Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats. Hu GX, Lin H, Lian QQ, Zhou SH, Guo J, Zhou HY, Chu Y, Ge RS. PLoS One; 2013 Mar 25; 8(3):e49976. PubMed ID: 23533564 [Abstract] [Full Text] [Related]
12. Inhibition of human and rat 11β-hydroxysteroid dehydrogenases activities by bisphenol A. Guo J, Yuan X, Qiu L, Zhu W, Wang C, Hu G, Chu Y, Ye L, Xu Y, Ge RS. Toxicol Lett; 2012 Nov 30; 215(2):126-30. PubMed ID: 23069880 [Abstract] [Full Text] [Related]
13. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group. Kwon SW, Kang SK, Lee JH, Bok JH, Kim CH, Dal Rhee S, Jung WH, Kim HY, Bae MA, Song JS, Ha DC, Cheon HG, Kim KY, Ahn JH. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):435-9. PubMed ID: 21093259 [Abstract] [Full Text] [Related]
14. Effects of bile acids on rat hepatic microsomal type I 11beta-hydroxysteroid dehydrogenase. Maeda Y, Naganuma S, Niina I, Shinohara A, Koshimoto C, Kondo K, Chijiiwa K. Steroids; 2010 Feb 01; 75(2):164-8. PubMed ID: 19948178 [Abstract] [Full Text] [Related]
15. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds. Blum A, Favia AD, Maser E. Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):132-6. PubMed ID: 18822345 [Abstract] [Full Text] [Related]
16. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes. Tagawa N, Kubota S, Kato I, Kobayashi Y. J Endocrinol; 2013 Sep 25; 218(3):311-20. PubMed ID: 23814014 [Abstract] [Full Text] [Related]
17. Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). Ye XY, Yoon D, Chen SY, Nayeem A, Golla R, Seethala R, Wang M, Harper T, Sleczka BG, Apedo A, Li YX, He B, Kirby M, Gordon DA, Robl JA. Bioorg Med Chem Lett; 2014 Jan 15; 24(2):654-60. PubMed ID: 24360604 [Abstract] [Full Text] [Related]
18. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver. Quinkler M, Jussli J, Bähr V, Pfeiffer AF, Lepenies J, Diederich S. Horm Metab Res; 2007 Aug 15; 39(8):555-9. PubMed ID: 17712719 [Abstract] [Full Text] [Related]
19. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors. Cho YS, Kim CH, Cheon HG. Anal Biochem; 2009 Sep 15; 392(2):110-6. PubMed ID: 19497289 [Abstract] [Full Text] [Related]
20. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice. Dhanesha N, Joharapurkar A, Shah G, Kshirsagar S, Dhote V, Sharma A, Jain M. Clin Exp Pharmacol Physiol; 2012 Jan 15; 39(1):69-77. PubMed ID: 22060140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]